tiprankstipranks
Qrons Inc. (QRON)
OTHER OTC:QRON
US Market

Qrons (QRON) Price & Analysis

5 Followers

QRON Stock Chart & Stats

$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)

QRON FAQ

What was Qrons Inc.’s price range in the past 12 months?
Qrons Inc. lowest stock price was $0.01 and its highest was $0.14 in the past 12 months.
    What is Qrons Inc.’s market cap?
    Qrons Inc.’s market cap is $198.86K.
      When is Qrons Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Qrons Inc.’s earnings last quarter?
      Currently, no data Available
      Is Qrons Inc. overvalued?
      According to Wall Street analysts Qrons Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Qrons Inc. pay dividends?
        Qrons Inc. does not currently pay dividends.
        What is Qrons Inc.’s EPS estimate?
        Qrons Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Qrons Inc. have?
        Qrons Inc. has 17,914,999 shares outstanding.
          What happened to Qrons Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Qrons Inc.?
          Currently, no hedge funds are holding shares in QRON
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Qrons Inc.

            Qrons Inc., a biotechnology company, engages in development of biotech products, treatments, and technologies to combat neuronal diseases. Its product candidates include QS100, an injury specific, 3D printable, implantable mesenchymal stem cells (MSCs)-synthetic hydrogel to treat penetrating brain injuries; and QS200, an injectable MSCs-synthetic hydrogel for the treatment of concussions and other diffused axonal injuries. The company was formerly known as BioLabMart Inc. and changed its name to Qrons Inc. in August 2017. Qrons Inc. was incorporated in 2016 and is based in Long Island City, New York.
            Similar Stocks
            Company
            Price & Change
            Follow
            Scinai Immunotherapeutics
            Aditxt
            CERo Therapeutics Holdings
            Psyence Biomedical
            CDT Equity
            Popular Stocks